A woman's account of being unable to secure treatment for debilitating perimenopause symptoms until her husband accompanied her to a doctor's appointment has amplified concerns about systemic gaps in women's healthcare. The patient shared that her doctors repeatedly dismissed her symptoms for years, attributing them to stress or aging, until her husband corroborated her experience.
This situation highlights a broader issue in medicine: a historical and ongoing underrepresentation of women in research and a tendency to minimize women's health concerns. Until 1993, women were frequently excluded from clinical trials, leading to a "medical gender gap" that continues to affect diagnosis and treatment. Experts note that many healthcare providers lack sufficient training in women's hormones, particularly during midlife stages like perimenopause, when symptoms can be highly individualized and elusive.
A 2026 study examining healthcare access across 29 countries found that women reported poorer access than men in 24 of them, with disparities particularly pronounced around age 50. This is the age range when many women navigate perimenopause and menopause. The Association of Medical Colleges reports research indicating that women's pain is often misunderstood or dismissed by clinicians, and hormonal conditions like endometriosis can still take seven to 10 years to diagnose.
Dr. Jessica Duncan, chief medical officer at integrative IVIM Health, stated that hormones are "one of the most under-appreciated levers in women's health." She added that the "downstream immune and inflammatory effects of declining estrogen and progesterone say everything about how long women’s midlife health has been an afterthought in medicine."
Similar experiences are being shared by many women online, particularly in forums and social media groups where they exchange stories of medical gaslighting and navigate what they describe as a biased healthcare system. Some women report seeing multiple specialists and being prescribed psychiatric medication or SSRIs instead of hormone replacement therapy (HRT).
HRT, which replaces declining estrogen and progesterone around menopause, can alleviate symptoms such as hot flashes, night sweats, sleep disturbances, and vaginal dryness. For many, it is life-changing, restoring energy and a sense of self. However, decades of fear surrounding potential risks like breast cancer and cardiovascular issues, largely stemming from outdated medical guidance and research, have deterred many from seeking or receiving this treatment. The FDA has begun revising broad black box warnings, indicating that women initiating HRT within 10 years of menopause onset generally experience reduced all-cause mortality, fractures, cardiovascular diseases, and Alzheimer's disease.
Changing deeply ingrained medical perspectives may take time, especially since women's hormonal health often spans multiple medical specialties, leading to fragmented care where no single provider connects all the dots. This fragmented approach has contributed to a rise in private and telehealth menopause clinics, where women seek out specialized providers who offer more dedicated time and expertise for symptoms that traditional offices have overlooked.
The growing demand for better answers and specialized care reflects a generational shift, with women increasingly advocating for comprehensive understanding and treatment of their bodies' complex hormonal changes. As one patient's experience suggests, advocating for adequate care should not require extraordinary measures.